Roche receives FDA approval for first companion diagnostic to identify.
The Pharma Data
AUGUST 19, 2021
Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company’s commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. Defects in the MMR machinery have been attributed to mutations in the MMR proteins.
Let's personalize your content